Improving the prognostic accuracy in renal cell carcinoma with venous thrombus with novel predictive nomograms.
作者信息
Zapała Łukasz, Kunc Michał, Radziszewski Piotr
机构信息
Clinic of General, Oncological and Functional Urology, Medical University of Warsaw, Warsaw, Poland.
Department of Pathomorphology, Medical University of Gdansk, Gdańsk, Poland.
出版信息
Transl Androl Urol. 2022 Oct;11(10):1361-1364. doi: 10.21037/tau-22-622.
Abstract
摘要
相似文献
1
Improving the prognostic accuracy in renal cell carcinoma with venous thrombus with novel predictive nomograms.使用新型预测列线图提高肾细胞癌伴静脉血栓形成的预后准确性。
Transl Androl Urol. 2022 Oct;11(10):1361-1364. doi: 10.21037/tau-22-622.
2
Predictive Nomogram for Recurrence following Surgery for Nonmetastatic Renal Cell Cancer with Tumor Thrombus.预测非转移性肾细胞癌伴肿瘤血栓手术后复发的列线图
J Urol. 2017 Oct;198(4):810-816. doi: 10.1016/j.juro.2017.04.066. Epub 2017 Apr 12.
3
Prognostic indicators for survival in renal cell carcinoma with venous thrombus and development of predictive nomograms.肾细胞癌伴静脉血栓形成患者生存的预后指标及预测列线图的制定
Transl Androl Urol. 2022 Oct;11(10):1374-1388. doi: 10.21037/tau-22-128.
4
Preoperative multivariable prognostic models for prediction of survival and major complications following surgical resection of renal cell carcinoma with suprahepatic caval tumor thrombus.术前多变量预后模型用于预测伴有肝上腔静脉瘤栓的肾细胞癌手术切除后的生存情况和主要并发症。
Urol Oncol. 2015 Sep;33(9):388.e1-9. doi: 10.1016/j.urolonc.2015.04.010. Epub 2015 May 23.
5
Venous tumor thrombus consistency is not predictive of survival in patients with renal cell carcinoma: A retrospective study of 147 patients.静脉肿瘤血栓的一致性不能预测肾细胞癌患者的生存率：一项对147例患者的回顾性研究。
Int J Urol. 2015 Jun;22(6):534-9. doi: 10.1111/iju.12738. Epub 2015 Mar 23.
6
A proposal of post-operative nomogram for overall survival in patients with renal cell carcinoma and venous tumor thrombus.肾细胞癌合并静脉瘤栓患者术后总生存列线图的建议
J Surg Oncol. 2017 Jun;115(7):905-912. doi: 10.1002/jso.24575. Epub 2017 Feb 23.
7
Nomogram for predicting survival of renal cell carcinoma with tumor thrombus based on perioperative clinicopathological factors from a Chinese high-volume center.基于中国大样本中心围手术期临床病理因素的肾细胞癌伴肿瘤栓nomogram 预测生存。
Int J Urol. 2022 Sep;29(9):984-993. doi: 10.1111/iju.14913. Epub 2022 Apr 26.
8
Nomograms for Predicting Overall Survival and Cancer-Specific Survival of Patients With Renal Cell Carcinoma and Venous Tumor Thrombus: A Population-Based Study.预测肾细胞癌合并静脉瘤栓患者总生存和癌症特异性生存的列线图：一项基于人群的研究
Front Surg. 2022 Jun 8;9:929885. doi: 10.3389/fsurg.2022.929885. eCollection 2022.
9
Prognostic factors for renal cell carcinoma with tumor thrombus extension.伴有肿瘤血栓延伸的肾细胞癌的预后因素
J Urol. 2007 Oct;178(4 Pt 1):1189-95; discussion 1195. doi: 10.1016/j.juro.2007.05.134. Epub 2007 Aug 14.
10
Prognostic significance of tumor extension into venous system in patients undergoing surgical treatment for renal cell carcinoma with venous tumor thrombus.手术治疗肾细胞癌伴静脉瘤栓患者肿瘤侵犯静脉系统对预后的意义。
Eur J Surg Oncol. 2012 Jul;38(7):630-6. doi: 10.1016/j.ejso.2012.03.006. Epub 2012 Apr 10.
本文引用的文献
1
Prognostic indicators for survival in renal cell carcinoma with venous thrombus and development of predictive nomograms.肾细胞癌伴静脉血栓形成患者生存的预后指标及预测列线图的制定
Transl Androl Urol. 2022 Oct;11(10):1374-1388. doi: 10.21037/tau-22-128.
2
Effect of Inferior Vena Cava Tumor Thrombus on Overall Survival in Metastatic Renal Cell Carcinoma Patients Treated with Cytoreductive Nephrectomy.下腔静脉肿瘤血栓对接受减瘤性肾切除术治疗的转移性肾细胞癌患者总生存期的影响。
Eur Urol Open Sci. 2022 Aug 30;44:94-101. doi: 10.1016/j.euros.2022.08.011. eCollection 2022 Oct.
3
Decoding the multicellular ecosystem of vena caval tumor thrombus in clear cell renal cell carcinoma by single-cell RNA sequencing.通过单细胞 RNA 测序解码透明细胞肾细胞癌下腔静脉癌栓的多细胞生态系统。
Genome Biol. 2022 Mar 31;23(1):87. doi: 10.1186/s13059-022-02651-9.
4
Evaluation of PD-L1 (E1L3N, 22C3) expression in venous tumor thrombus is superior to its assessment in renal tumor in predicting overall survival in renal cell carcinoma.评估肾细胞癌中静脉瘤栓的 PD-L1（E1L3N，22C3）表达优于肿瘤组织，可预测患者总生存期。
Urol Oncol. 2022 May;40(5):200.e1-200.e10. doi: 10.1016/j.urolonc.2022.02.001. Epub 2022 Mar 26.
5
Low Lymphocyte-to-Monocyte Ratio Is the Potential Indicator of Worse Overall Survival in Patients with Renal Cell Carcinoma and Venous Tumor Thrombus.低淋巴细胞与单核细胞比值是肾细胞癌合并静脉瘤栓患者总生存期较差的潜在指标。
Diagnostics (Basel). 2021 Nov 21;11(11):2159. doi: 10.3390/diagnostics11112159.
6
Three Years After CARMENA: What Have We Learned?卡门娜事件三年后：我们有何收获？
Eur Urol. 2021 Oct;80(4):425-427. doi: 10.1016/j.eururo.2021.07.007. Epub 2021 Jul 27.
7
Predictive factors of recurrence after surgery in patients with non-metastatic renal cell carcinoma with venous tumor thrombus (UroCCR-56 Study).非转移性肾细胞癌伴静脉瘤栓患者术后复发的预测因素（UroCCR - 56研究）
World J Urol. 2023 Feb;41(2):295-302. doi: 10.1007/s00345-021-03640-6. Epub 2021 Mar 25.
8
Surgical Safety of Cytoreductive Nephrectomy Following Sunitinib: Results from the Multicentre, Randomised Controlled Trial of Immediate Versus Deferred Nephrectomy (SURTIME).舒尼替尼治疗后的细胞减灭性肾切除术的手术安全性：即时与延迟肾切除术（SURTIME）多中心随机对照试验的结果。
Eur Urol. 2019 Oct;76(4):437-440. doi: 10.1016/j.eururo.2019.06.006. Epub 2019 Jun 18.
9
Long-term survival and prognostic factors for locally advanced renal cell carcinoma with renal vein tumor thrombus.局部进展期肾细胞癌合并肾静脉瘤栓的长期生存及预后因素。
BMC Cancer. 2019 Feb 13;19(1):144. doi: 10.1186/s12885-019-5359-0.
10
A systematic review and meta-analysis of clinicopathologic factors linked to oncologic outcomes for renal cell carcinoma with tumor thrombus treated by radical nephrectomy with thrombectomy.根治性肾切除术联合血栓切除术治疗肾细胞癌伴肿瘤血栓的临床病理因素与肿瘤学结局关系的系统评价和荟萃分析。
Cancer Treat Rev. 2018 Sep;69:112-120. doi: 10.1016/j.ctrv.2018.06.014. Epub 2018 Jun 21.
Zotero 插件